Human Anti-IL23 x Anti-IL6 Bispecific Antibody (IgG-IgG) (BSIG-H342)

Anti-IL23 x Anti-IL6 Bispecific Antibody (IgG-IgG) is designed to be generated by crosslinking two full length IgGs, anti-IL23 and anti-IL6 parental antibodies. A stable linkage is formed between the two antibodies. This BsAb can block two proinﬂammatory cytokines simultaneously. It is designed for the research of Inflammatory diseases therapy.

Datasheet INQUIRY

Specifications

Targets

IL23 & IL6

Type

IgG-IgG

Species Reactivity

Human

Application

FuncS; Promising therapeutic agent

Related Disease

Inflammatory diseases

Targets

Target 1

IL23

Gene ID

51561

UniProt ID

Q9NPF7

Alternative Names

P19; SGRF; IL-23; IL-23A; IL23P19; Interleukin-23; IL23; interleukin 23 subunit alpha

Target 2

IL6

Gene ID

3569

UniProt ID

P05231

Alternative Names

CDF; HGF; HSF; BSF2; IL-6; BSF-2; IFNB2; IFN-beta-2; interleukin 6; IL6

Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.

Online Inquiry

Customer Reviews and Q&As

There are currently no customer reviews or questions for Human Anti-IL23 x Anti-IL6 Bispecific Antibody (IgG-IgG) (BSIG-H342). Click the button below to contact us or submit your feedback about this product.

Human Anti-IL23 x Anti-IL6 Bispecific Antibody (IgG-IgG) (CAT#: BSIG-H342)

Specifications

Targets

Customer Reviews and Q&As